Federal health officials are conducting research into the effects of the Modern COVID-19 vaccine after new research showed that it may be related to a higher risk of heart inflammation in young adults than before, according to a Washington Post report.
Two people familiar with the review told the Post that the heart disease, called myocarditis, is probably still extremely rare, but added that the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are studying new Canadian data that suggest a higher risk among a population specific demographic that the Modern vaccine has received.
Sources, who spoke on condition of anonymity, said the research shows a potential risk of heart inflammation among Modern than Pfizer-BioNTech receptors, especially for men under 30 years of age.
The FDA added a warning label to the two mRNA vaccines in June about the potential increased risk of myocarditis, though the CDC, the Department of Health and Human Services (HHS) and 15 of the leading medical professionals nationals. and public health organizations said in a joint statement that the risk of heart inflammation was much higher among people infected with COVID-19.
“The facts are clear: this is an extremely rare side effect and only an extremely small number of people will experience it after vaccination,” the groups said in a statement at the time. “It’s important to note that for young people who do, most cases are mild and people often recover on their own or with minimal treatment.”
In response to the Post report, FDA spokeswoman Stephanie Caccomo said the agency would not discuss internal meetings and deliberations, but added that it is “absolutely committed to reviewing the data as it becomes available for We”.
“We have previously communicated about myocarditis and COVID-19 vaccines and if the new information changes the risk / benefit profile, we will update the public accordingly,” Caccomo said.
The CDC said that “the Advisory Committee on Immunization Practices has reviewed and continues to review reports of myocarditis and pericarditis following COVID-19 mRNA vaccination.”
“The CDC, the FDA and our vaccine safety partners are actively monitoring these reports, including reviewing medical data and records, to learn more and understand any relationship to COVID-19 mRNA vaccination,” he said. add the CDC, according to the Post.
The Hill has contacted Moderna to comment.
Last month, a The European Medicines Agency (EMA) committee echoed that heart inflammation was “very rare” among COVD-19 mRNA receptors.